Stock 2251 BEIJING AIRDOC TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Beijing Airdoc Technology Co., Ltd.

Equities

2251

CNE100004QQ9

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-07-18 EDT 		5-day change 1st Jan Change
12.48 HKD -2.80% Intraday chart for Beijing Airdoc Technology Co., Ltd. -10.22% +3.14%
04-17 Beijing Airdoc Arm Setting Up 500 Million Yuan Fund MT
03-27 Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
BEIJING AIRDOC TECHNOLOGY CO., LTD. Stock Beijing Airdoc Technology Co., Ltd.
+3.14% 169M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-5.50% 29.41B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+37.09% 9.45B
C-
SECTRA AB Stock Sectra AB
+31.37% 4.34B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-36.88% 2.39B
C-
VERADIGM INC. Stock Veradigm Inc.
-6.48% 1.66B -
C+
OMNICELL, INC. Stock Omnicell, Inc.
-23.84% 1.32B
B
LUNIT INC. Stock Lunit Inc.
-42.92% 977M -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-3.96% 860M
C
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-50.69% 687M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2251 Stock
  4. Ratings Beijing Airdoc Technology Co., Ltd.